Distinct Genetic Signatures Despite Similar Yield in Pediatric Dilated Cardiomyopathy and Myocarditis
The Thoracic and Cardiovascular Surgeon · 2026-01 · 74 (S 02) · S71-S98
DOI: 10.1055/s-0046-1817368 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, online erschienen am 17.02.2026. Verfasst von F. Seidel und 6 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
Dilated cardiomyopathy (DCM) and myocarditis are leading causes of severe pediatric heart failure. Although considered distinct, myocarditis can present with a dilated phenotype (MycDCM). Pathogenic variants are found in about one-third of DCM patients, predominantly in sarcomere genes, but the genetic profile of MycDCM is less well defined.
Methods
We retrospectively analyzed 138 children with DCM (2013–2023). Genetic testing included cardiomyopathy panels, whole-exome (WES), or whole-genome sequencing (WGS). Variants were classified per ACMG criteria; only likely pathogenic/pathogenic (LP/P) were considered. Syndromic cases were excluded. Myocarditis was biopsy-proven.
Results
All patients underwent genetic testing (78 WES/WGS, 60 panel). Eighty-one (59%) were diagnosed with DCM, 57 (41%) with MycDCM. LP/P variants were detected in 34 patients: 21/81 (26%) DCM and 13/57 (23%) MycDCM. In the DCM group, median age at symptom onset was 0.4 years (IQR: 0.0–10.3); 62% female. Sarcomere variants predominated (71%; 15/21), affecting TNNT2 ( n = 4), TNNI3 ( n = 3), TPM1 ( n = 3), MYBPC3 ( n = 2), MYH7, ACTC1, ACTN2 ( n = 1, respectively). In MycDCM patients median symptom onset was 3.1 years (IQR: 0.5–8.4); 54% female. Variants included genes linked to cytoskeletal integrity and inflammation (BAG3, LMNA n = 2; FLNC, DES n = 1) about half were sarcomere variants (54%; 7/13): TNNT2, TNNI3, TTN n = 2, respectively; MYH7 n = 1. Transplantation was performed in 52% of genetically positive DCM and 69% of MycDCM patients. Mortality occurred in three DCM patients, none in MycDCM. One MycDCM patient recovered after ventricular assist device support.
Conclusion
Genetic yield was similar in pediatric DCM and MycDCM, but gene patterns differed. Primary DCM presented earlier in childhood and was dominated by sarcomere variants, whereas MycDCM more often carried variants linked to cytoskeletal and inflammatory pathways. Integrated phenotyping and genetic testing are essential for accurate diagnosis and management of pediatric heart failure. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Seidel, F., Shcherbakova, N., Brendel, J., Berger, F., Pickardt, T., Rolfs, N., & Klaassen, S. (2026). Distinct Genetic Signatures Despite Similar Yield in Pediatric Dilated Cardiomyopathy and Myocarditis. The Thoracic and Cardiovascular Surgeon, 74(S 02), S71-S98. https://doi.org/10.1055/s-0046-1817368
Vancouver
Seidel F, Shcherbakova N, Brendel J, Berger F, Pickardt T, Rolfs N, et al. Distinct Genetic Signatures Despite Similar Yield in Pediatric Dilated Cardiomyopathy and Myocarditis. The Thoracic and Cardiovascular Surgeon. 2026;74(S 02):S71-S98. doi:10.1055/s-0046-1817368
BibTeX
@article{Seidel2026,
author = {Seidel, F. and Shcherbakova, N. and Brendel, J. and Berger, F. and Pickardt, T. and Rolfs, N. and Klaassen, S.},
title = {Distinct Genetic Signatures Despite Similar Yield in Pediatric Dilated Cardiomyopathy and Myocarditis},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 02},
pages = {S71--S98},
doi = {10.1055/s-0046-1817368}
}
EUVIMED